A140410 Share Price Performance
₩0
-36700.00 (-100.00%)
Price ₩0
Share Pricen/a
Is Mezzion PharmaLtd (KOSDAQ:140410) A Risky Investment?
Feb 06
Mezzion Pharma Co.,Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
A140410 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Mezzion Pharma Co.,Ltd. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -1.15k
- 17.46%
- -441.61%
- 57.6%
About A140410
- Founded
- 2002
- Employees
- 18
- CEO
- WebsiteView website
Mezzion Pharma Co.,Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company developing JURVIGO, which is in Phase 3 clinical trial for treatment option to improve the physiology and exercise capacity of Fontan patients 12 years and older. The company was formerly known as Dong-A Pharmtech Co., Ltd. and changed its name to Mezzion Pharma Co.,Ltd. in April 2013. Mezzion Pharma Co.,Ltd. was founded in 2002 and is headquartered in Seoul, South Korea.